No Data
No Data
No Data
No Data
No Data
Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share
PARSIPPANY, N.J., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Sio Gene Therapies, Inc. ("Sio") today announced that it expects to file a certificate of dissolution (the "Certificate of Dissolution") with the
GlobeNewswireFeb 2 20:00
Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7B, Sources Say -- WSJ
Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7B, Sources Say -- WSJ
Dow JonesJul 14, 2023 05:50
Roivant Was Started by Republican Presidential Candidate Vivek Ramaswamy -- WSJ
Roivant Was Started by Republican Presidential Candidate Vivek Ramaswamy -- WSJ
Dow JonesJul 14, 2023 05:50
Delisting of Securities of Core Scientific, Inc.; The Very Good Food Company Inc.; HyreCar Inc.; Reeds, Inc.; Sorrento Therapeutics, Inc.; CYREN Ltd.; Lucira Health, Inc.; Qutoutiao Inc.; and Sio Gene Therapies Inc. From The Nasdaq Stock Market
Globe NewswireApr 11, 2023 04:10
Sio Gene Therapies (NASDAQ:SIOX) Vs. Organigram (NASDAQ:OGI) Head-To-Head Review
Sio Gene Therapies (NASDAQ:SIOX – Get Rating) and Organigram (NASDAQ:OGI – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on
Defense WorldApr 1, 2023 13:31
Sio Gene Therapies 3Q Loss/Shr 5c >SIOX
Sio Gene Therapies 3Q Loss/Shr 5c >SIOX
Dow JonesFeb 14, 2023 20:09
No Data
No Data